Pharmacodynamics of NPC-01/IKH-01; Effect of NPC-01/IKH-01 on Sexual Hormone Concentrations in Healthy Female Volunteers
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01253824|
Recruitment Status : Completed
First Posted : December 3, 2010
Results First Posted : June 17, 2014
Last Update Posted : June 17, 2014
|Study Design||Allocation: Randomized; Intervention Model: Parallel Assignment; Masking: Single (Participant); Primary Purpose: Treatment|
Fifty one subjects were screened for this study after acquiring an informed consent.
18 subjects of those participated in pre-medication menstrual cycle phase to confirm baseline of estradiol, progesterone, FSH and LH.
4 subjects withdrew IC during this phase, therefore, 14 subjects were registered and allocated study drugs.